Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. Braz. J. Pharm. Sci. [Internet]. 2022 Nov. 9 [cited 2024 Jun. 2];57. Available from: https://periodicos.usp.br/bjps/article/view/204035